The epithelial era of asthma research : knowledge gaps and future direction for patient care
(2024) In European Respiratory Review 33(174).- Abstract
The Epithelial Science Expert Group convened on 18–19 October 2023, in Naples, Italy, to discuss the current understanding of the fundamental role of the airway epithelium in asthma and other respiratory diseases and to explore the future direction of patient care. This review summarises the key concepts and research questions that were raised. As an introduction to the epithelial era of research, the evolution of asthma management throughout the ages was discussed and the role of the epithelium as an immunefunctioning organ was elucidated. The role of the bronchial epithelial cells in lower airway diseases beyond severe asthma was considered, as well as the role of the epithelium in upper airway diseases such as chronic rhinosinusitis.... (More)
The Epithelial Science Expert Group convened on 18–19 October 2023, in Naples, Italy, to discuss the current understanding of the fundamental role of the airway epithelium in asthma and other respiratory diseases and to explore the future direction of patient care. This review summarises the key concepts and research questions that were raised. As an introduction to the epithelial era of research, the evolution of asthma management throughout the ages was discussed and the role of the epithelium as an immunefunctioning organ was elucidated. The role of the bronchial epithelial cells in lower airway diseases beyond severe asthma was considered, as well as the role of the epithelium in upper airway diseases such as chronic rhinosinusitis. The biology and application of biomarkers in patient care was also discussed. The Epithelial Science Expert Group also explored future research needs by identifying the current knowledge and research gaps in asthma management and ranking them by priority. It was identified that there is a need to define and support early assessment of asthma to characterise patients at high risk of severe asthma. Furthermore, a better understanding of asthma progression is required. The development of new treatments and diagnostic tests as well as the identification of new biomarkers will also be required to address the current unmet needs. Finally, an increased understanding of epithelial dysfunction will determine if we can alter disease progression and achieve clinical remission.
(Less)
- author
- author collaboration
- organization
- publishing date
- 2024-10
- type
- Contribution to journal
- publication status
- published
- subject
- in
- European Respiratory Review
- volume
- 33
- issue
- 174
- article number
- 240221
- publisher
- European Respiratory Society
- external identifiers
-
- scopus:85213185525
- pmid:39694589
- ISSN
- 0905-9180
- DOI
- 10.1183/16000617.0221-2024
- language
- English
- LU publication?
- no
- id
- 5aab9b06-4e68-4077-b5e1-019fb23d2030
- date added to LUP
- 2025-01-20 14:56:57
- date last changed
- 2025-07-08 04:30:39
@article{5aab9b06-4e68-4077-b5e1-019fb23d2030,
abstract = {{<p>The Epithelial Science Expert Group convened on 18–19 October 2023, in Naples, Italy, to discuss the current understanding of the fundamental role of the airway epithelium in asthma and other respiratory diseases and to explore the future direction of patient care. This review summarises the key concepts and research questions that were raised. As an introduction to the epithelial era of research, the evolution of asthma management throughout the ages was discussed and the role of the epithelium as an immunefunctioning organ was elucidated. The role of the bronchial epithelial cells in lower airway diseases beyond severe asthma was considered, as well as the role of the epithelium in upper airway diseases such as chronic rhinosinusitis. The biology and application of biomarkers in patient care was also discussed. The Epithelial Science Expert Group also explored future research needs by identifying the current knowledge and research gaps in asthma management and ranking them by priority. It was identified that there is a need to define and support early assessment of asthma to characterise patients at high risk of severe asthma. Furthermore, a better understanding of asthma progression is required. The development of new treatments and diagnostic tests as well as the identification of new biomarkers will also be required to address the current unmet needs. Finally, an increased understanding of epithelial dysfunction will determine if we can alter disease progression and achieve clinical remission.</p>}},
author = {{Brightling, Christopher E. and Marone, Gianni and Aegerter, Helena and Chanez, Pascal and Heffler, Enrico and Pavord, Ian D. and Rabe, Klaus F. and Dorscheid, Del and Bourdin, Arnaud and Brightling, Christopher E. and Chanez, Pascal and Eguiluz-Gracia, Ibon and Heffler, Enrico and Hiemstra, Pieter and Marone, Gianni and Palomares, Oscar and Rabe, Klaus F.}},
issn = {{0905-9180}},
language = {{eng}},
number = {{174}},
publisher = {{European Respiratory Society}},
series = {{European Respiratory Review}},
title = {{The epithelial era of asthma research : knowledge gaps and future direction for patient care}},
url = {{http://dx.doi.org/10.1183/16000617.0221-2024}},
doi = {{10.1183/16000617.0221-2024}},
volume = {{33}},
year = {{2024}},
}